Neurocrine Fair Value
NB
The fair market value of NBIX stock is 208.02 USD. Relative to the market price of 126.35 USD Neurocrine is undervalued by 64.6%
Eyestock's quantitative valuation approach is based on the method of estimating historical multipliers. To determine whether a stock is undervalued, we compare its current price to our estimated of fair value. The more undervalued a stock is, the more investment is profitable.
Fair Relative Value
Neurocrine Valuation
Current NBIX share ticker price is 126.35 USD.
The fair value level of 208.02 USD can be considered as an effective entry point for long-term investors to start investing in NBIX stock. For a more in-depth assessment, we provide a minimum value that can be used to increase a stock position and a maximum one that can be used to reduce it.
Price chart is not available
Current market price
Current price is 65% lower its fair value
Current price is 26% higher its minimum value
Current price is 404% lower its maximum value
Market price:
NBIX stock is undervalued
It means the current price may concern as a Moderate Risk Entry Point
Neurocrine Biosciences Inc Stock Valuation Calculator
How do we value a stock?
As fair value, we use the product of the median Price-to-earnings ratios at the end of each reporting period for the last 5 years and earnings per share for the last 12 months. By analogy with the fair value, we calculate the maximum and minimum ones using the corresponding P/E extremums.
1
Maximum P/E over 5 years
164.39
2
Median P/E over 5 years
53.74
3
Minimum P/E over 5 years
24.05
4
Earning per share (last 12 months)
3.87 USD
Maximum value
1
x
4
=
636.31 USD
Fair value
2
x
4
=
208.02 USD
Minimum value
3
x
4
=
93.09 USD
Neurocrine Biosciences Inc price metrics
3.1
Annual return (geometric mean)
36.59
Risk (standard deviation) of returns
β
0.34
Beta (volatility compared to market)